Healthcare Public Relations

Updated September 2026 · Written and maintained by the Progression Agency strategy team

Healthcare communications operates under constraints that do not apply elsewhere: claims attract substantiation expectations, patient privacy law governs storytelling, specialist journalists read the underlying evidence, and review involves legal, clinical and regulatory opinion rather than a marketing sign-off. This answers the questions organizations in health ask most often — about claims, consent, audiences, bad news and measurement.

What is healthcare public relations?

Communications work for organizations in health — providers, systems, medical device and life science companies, digital health and payers — conducted under regulatory constraints that do not apply to most other sectors.

The constraints are the defining feature. What can be claimed, who can be named, and what counts as promotion rather than information are all governed in ways that shape every piece of work.

How is healthcare PR different from ordinary PR?

Regulated claims, patient privacy, clinical accuracy, and a press corps that will check what you say against the evidence.

A claim that would be ordinary marketing language in another sector can be a regulatory problem here, which is why review processes exist and why they take time.

The audiences row is the one that changes strategy most. A statement written for patients is read by clinicians and regulators too, and it has to survive all three readings.

Who are the audiences and how do they differ?

Patients and carers, clinicians, payers and purchasers, regulators, investors and staff — and each judges the same statement by a different standard.

Writing for one audience and hoping the others do not read it is not available in this sector; everything is public and everything is checked.

Patients and carers

Need plain language, honest uncertainty, and no implied promise about individual outcomes.

Clinicians

Judge on evidence quality. Overstatement destroys credibility with this audience faster than with any other.

Payers and purchasers

Care about outcomes, cost and evidence of both, rather than about features.

Regulators

Read what you publish. Nothing is off the record, and consistency between what you tell them and what you say publicly matters.

Investors

In commercial health organizations, subject to their own disclosure rules, which constrain timing as well as content.

Staff and clinicians internally

Frequently the most credible external voice you have, and the most damaging if they are not informed.

What can and cannot be claimed?

That depends on what the organization is and what is being described — and it is a question for qualified regulatory and legal advice on the specific claim, not a general rule.

What is generally true is that claims about clinical outcomes attract scrutiny proportionate to how specific they are, and that the safest ground is describing what was measured rather than characterizing what it means.

Describe the evidence, not the conclusion

Saying what a study measured and in whom is more defensible than summarizing what it proves.

Avoid implied individual promises

Population-level findings do not translate to what any one person should expect, and language that blurs that is a real risk.

Be careful with comparatives

Comparative claims typically attract a higher substantiation burden than descriptive ones.

Get review before drafting is finished

Late regulatory review produces rewrites; early involvement produces workable drafts.

Keep the record

What was approved, by whom, on what date. It matters more here than in most sectors.

Take advice on your specific situation

Rules differ by organization type, product class and jurisdiction, and general guidance is not a substitute.

How does patient privacy affect storytelling?

Patient stories are among the most effective communications available and among the most tightly constrained — consent has to be specific, informed, documented and revocable.

The shortcut of using a story without proper consent is a legal exposure rather than a communications risk, and it is one of the few mistakes in this field that cannot be repaired.

The typicality row is where good intentions most often create a regulatory problem: a true story presented in a way that suggests a typical result functions as an outcome claim.

What does a healthcare PR program usually include?

Media relations with general and trade press, thought leadership from credible clinicians, data and study communications, issues management, and internal communications.

The proportions vary enormously by organization type. A hospital system, a device manufacturer and a digital health company have almost nothing in common in what they actually need.

How do you work with specialist health journalists?

By being accurate, being available, and accepting that they will read the underlying evidence rather than the press release.

Health and trade journalists in this field are frequently more expert than the person briefing them, which makes overstatement counterproductive in a way it is not elsewhere.

Send the evidence, not just the summary

Journalists who can read the study will, and withholding it reads as evasion.

Be honest about limitations

Sample size, population, follow-up period. Volunteering these builds credibility that survives the next story.

Offer credible spokespeople

Clinicians who can answer detailed questions rather than communications staff reading approved language.

Respect embargoes and deadlines

Both are taken seriously and breaking either has lasting consequences with a small press corps.

Do not oversell early-stage work

Preliminary findings described as breakthroughs damage credibility for years.

Correct errors quickly and privately first

Public correction demands rarely improve the relationship or the coverage.

What are the common mistakes?

Overstating evidence, using patient stories without proper consent, treating regulatory review as an obstacle, and being slow when something goes wrong.

The first three are avoidable with process. The fourth is avoidable with preparation, and it is the one that does the most damage when it happens.

How should healthcare organizations handle bad news?

Rapidly, factually, with patient safety addressed first and regulatory obligations met — and with communications and legal working together rather than sequentially.

Health incidents frequently carry mandatory reporting duties with fixed deadlines, which constrains the communications timeline in ways that must be understood in advance.

What is the role of internal communications?

Central. Clinical and support staff are the most credible voices about an organization and the first people patients ask.

Staff who learn about something from the news become an uncontrolled and understandably unhappy channel, which is a communications failure with clinical consequences in this sector.

How is healthcare PR measured?

Reach in the publications the relevant audiences actually read, share of voice on the issues that matter, and the specific outcomes the program exists to support.

Coverage volume alone is a poor measure here, because one trade article read by the right two hundred people can matter more than a national mention.

The last row is the one nobody reports and everybody values: a program that has produced no regulatory problems has achieved something real, and no dashboard shows it.

Should you hire a healthcare specialist or a generalist agency?

A specialist where regulated claims, clinical evidence or trade press are central. A generalist can work where the communications are essentially ordinary and the sector is incidental.

The test is whether the work will routinely require judgment about what can be said, because that judgment is what specialist experience actually buys.

What should you ask a healthcare PR agency?

How they handle regulatory review, who on the team has clinical or regulatory background, how they handle patient consent, and what they would refuse to say.

The consent question is the most diagnostic. An agency without a documented process for patient stories has not done much healthcare work.

How does healthcare PR differ across organization types?

A hospital system, a device manufacturer, a digital health company and a payer face different regulators, different audiences and different claim rules — and almost nothing transfers between them unexamined.

This is the main reason sector experience matters more here than in most fields: the constraints are specific rather than general.

The digital health row is the most volatile: evidence expectations for that category are still forming, and what passed without challenge a few years ago increasingly does not.

What should you prepare before you need it?

A consent process and template, a named clinical reviewer, a regulatory review path with an agreed turnaround, holding statements, and a trained clinical spokesperson.

Every item on that list saves days at the moment it is needed, and none of it can be built while something is going wrong.

How do you brief a clinician to speak publicly?

By agreeing what is being claimed before any interview, checking that they are comfortable with the limits of the evidence, and preparing the questions they will be asked about it.

Clinicians are frequently more cautious than the communications team and more precise than the marketing language. Both of those are assets rather than obstacles.

What do you do when the evidence is weaker than the marketing wants it to be?

You describe what the evidence actually supports and change the marketing, rather than describing the evidence in language it does not support.

This is the recurring tension in healthcare communications, and it is the one where an agency or internal team earns its position by being willing to lose the argument in the right direction.

The final row is the one that separates teams that work well with regulatory review from those in permanent conflict with it: asking what would be supportable produces publishable material, and rewording until something slips through produces a problem later.

How to decide what belongs in an FAQ

Questions people actually ask, taken from support tickets, sales calls and site search. Invented questions are recognisable and add nothing.

When an FAQ is the wrong format

When the answer belongs in the flow of the page. Burying a critical fact in an accordion at the bottom is how important information gets missed.

Frequently asked questions